SOBRsafe (NASDAQ: SOBR), a Colorado-based provider of next-generation transdermal alcohol detection technology, has just announced the launch of its fully integrated enterprise software solution that is expected to transform how health providers monitor and manage…
In recent years, cryptocurrency has captured the imagination of investors, who have embraced it as a revolutionary asset class offering high-growth potential. With Bitcoin and other digital currencies reaching new heights, many investors have turned…
CNS Pharmaceuticals (NASDAQ: CNSP) reported Q3 2024 financial results and highlighted clinical advancements, including the ongoing potentially pivotal trial of Berubicin, a targeted chemotherapy for recurrent glioblastoma multiforme (“GBM”). Enrollment of 252 patients was completed,…
Mullen Automotive (NASDAQ: MULN) announced a partnership with National Auto Fleet Group (“NAFG”) to sell its all-electric Class 4 Bollinger B4 commercial trucks to government agencies via NAFG’s Sourcewell-awarded contract. The Bollinger B4, designed with…
NextPlat (NASDAQ: NXPL, NXPLW) reported Q3 2024 results reflecting the impact of its recent acquisitions, including Progressive Care and Outfitter Satellite, which contributed to consolidated revenues of $15.4 million. While healthcare revenue declined due to…
McEwen Mining (NYSE: MUX) (TSX: MUX) is positioned to benefit from increased investor interest in precious metals as well as growing demand for critical minerals. “McEwen Mining is a gold and silver producer with operations…
Annovis Bio (NYSE: ANVS), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases, such as Alzheimer’s disease (“AD”) and Parkinson’s disease (“PD”), concluded the third quarter with significant milestones achieved and a…
Kairos Pharma (NYSE American: KAPA) is a clinical-stage biopharmaceutical company focused on advancing innovative oncology therapeutics that target drug resistance and immune suppression, two significant barriers in effective cancer treatment. By addressing these mechanisms, Kairos…
SOBRsafe (NASDAQ: SOBR), a provider of next-generation transdermal alcohol screening and monitoring solutions, recently raised $8.2 million in gross proceeds from a private placement with certain institutional investors. The company expects to use the net…
Annovis Bio (NYSE: ANVS) announced that its President and CEO, Dr. Maria Maccecchini, will speak at the National Institute on Aging’s (NIA) workshop, “Dementia with Lewy Bodies: Filling the Gaps in Translational and Clinical Research.” Scheduled…
Cogna, an artificial intelligence software firm, just brought in $15 million in new backing. The company has the largest gas distribution network in Britain among its clients. This latest funding includes investment from key venture capital…
D-Wave Quantum (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software and services, and the first commercial provider of quantum computers, has been deemed “Awardable” through the Department of Defense (“DoD”) Chief Digital and Artificial…
Cepton (NASDAQ: CPTN) shared updates for Q3 2024, highlighting advancements in its lidar technology commercialization, with a major long-range lidar RFQ in final stages with a Top 10 global automotive OEM. Cepton’s CEO, Jun Pei,…
McEwen Mining (NYSE: MUX) (TSX: MUX) has strengthened its support for Inventus Mining Corp. (TSXV: IVS) by acquiring 10,000,000 units in Inventus’s recently closed private placement, contributing $400,000 toward the $600,000 raised. Each unit in the…
Mullen Automotive (NASDAQ: MULN) announced that Bollinger Motors has qualified for New York State’s New York Truck Voucher Incentive Program (“NYTVIP”), offering up to a $100,000 voucher for its all-electric B4 Truck. This incentive, provided…
D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software and services, and the first commercial provider of quantum computers, appointed two veteran technology industry leaders to its board of directors, supporting the…
D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”) announced it has achieved “Awardable” status in the US Department of Defense’s (DoD) Tradewinds Solutions Marketplace, which showcases cutting-edge technologies for potential DoD adoption. This designation endorses D-Wave’s annealing quantum…
Annovis (NYSE: ANVS), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases such as Alzheimer’s disease (“AD”) and Parkinson’s disease (“PD”), presented two scientific posters at the 17th Clinical Trials on Alzheimer’s…
President Biden has rolled out a new plan aimed at enabling the U.S. to harness AI for national security purposes amid a global race that is seeing different countries scrambling to tap this new technology…
CNS Pharmaceuticals (NASDAQ: CNSP) announced that it received an exception from the Nasdaq Hearings Panel, granting the company until March 11, 2025, to meet the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2). This…
SOBRsafe (NASDAQ: SOBR) announced its compliance with Nasdaq’s listing standards, meeting minimum bid price, public float, and stockholders’ equity requirements per the August 2024 Nasdaq Hearings Panel decision. As a result, SOBRsafe’s common stock will…
HeartBeam (NASDAQ: BEAT), a medical technology company focused on enhancing cardiac care through advanced insights, will hold a conference call on November 7, 2024, at 4:30 p.m. ET to discuss third-quarter results and share updates…
Annovis Bio (NYSE: ANVS) led by Founder, President and CEO Dr. Maria Maccecchini, shares exciting developments regarding its pioneering Alzheimer’s and Parkinson’s drug candidate, buntanetap. In her interview on IBN’s BioMedWire Podcast, Dr. Maccecchini discusses…
Annovis Bio (NYSE: ANVS) is a late-stage clinical drug platform company pioneering novel therapies for neurodegenerative diseases. Recent clinical trials of the company’s lead compound yielded encouraging results, with buntanetap shown to improve cognition in…
While it is common knowledge that investors in tech firms like Nvidia Corp. (NASDAQ: NVDA) are accumulating fortunes from AI, the island of Anguilla is also minting serious cash from this industry. This started at…
Argentina is rapidly emerging as a key player in the global mining industry, positioning itself to become a significant producer of copper and other minerals critical to the world’s clean energy transition. The country’s ambition…
Annovis Bio (NYSE: ANVS), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases such as Alzheimer’s disease (“AD”) and Parkinson’s disease (“PD”), recently secured the approval of the U.S. Food and Drug…
D-Wave Quantum (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software and services, and the first commercial provider of quantum computers, recently participated in the 2024 INFORMS Annual Meeting, highlighting its quantum optimization solutions and…
Clene (NASDAQ: CLNN) and its wholly owned subsidiary Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”) and…
Behind the crime statistics related to domestic violence, and efforts to provide a supportive society to its victims, are personal stories of fear and loss, as exhibited by the son of a domestic violence victim…
HeartBeam (NASDAQ: BEAT), a medical technology company focused on advancing cardiac care, was recognized with the 2024 Digital Health Hub Rising Star award in the ‘Home Health Diagnostic’ category at the HLTH global healthcare conference.…
Annovis Bio (NYSE: ANVS), a late-stage clinical drug platform company focused on developing transformative therapies for neurodegenerative disorders, including Alzheimer’s disease (“AD”) and Parkinson’s disease (“PD”), recently announced a significant milestone in its drug development…
Artificial intelligence is rapidly reshaping the landscape of economies around the world. Estimates indicate that generative AI alone will triple its growth to a total market value of $1.3 trillion in the next decade. As…
Geoffrey Hinton, undeniably referred to as “the Godfather of AI,” has been awarded the Nobel Prize in Physics alongside John Hopfield for their groundbreaking work that triggered the development of machine learning, the science behind…
Clene (NASDAQ: CLNN) and its wholly owned subsidiary, Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”) multiple…